Jump to content

Ogilvie syndrome

From Wikipedia, the free encyclopedia
(Redirected from Ogilvie's syndrome)
Ogilvie syndrome
Other namesAcute colonic pseudo-obstruction
CT-Scan showing a coronal section of the abdomen of an elderly woman with Ogilvie syndrome
SpecialtyGastroenterology Edit this on Wikidata

Ogilvie syndrome, or acute colonic pseudo-obstruction is the acute dilatation of the colon in the absence of any mechanical obstruction in severely ill patients.[1]

Acute colonic pseudo-obstruction is characterized by massive dilatation of the cecum (diameter > 10 cm) and right colon on abdominal X-ray.[2][3] It is a type of megacolon, sometimes referred to as "acute megacolon," to distinguish it from toxic megacolon.

The condition carries the name of the British surgeon Sir William Heneage Ogilvie (1887–1971), who first reported it in 1948.[4][5][6]

Ogilvie syndrome is an acute illness, which means it occurs suddenly and temporarily, and it only affects the colon. "Intestinal pseudo-obstruction" is a broad term that refers to any paralysis of the intestines that is not caused by a mechanical obstruction. Some individuals develop chronic intestinal pseudo-obstruction as a result of a chronic disease or a congenital condition.[7]

Signs and symptoms

[edit]

Usually the patient has abdominal distention, pain and altered bowel movements.[2][8] There may also be nausea and vomiting.[9]

Cause

[edit]

Ogilvie syndrome may occur after surgery, especially following coronary artery bypass surgery and total joint replacement.[10] Drugs that disturb colonic motility (such as anticholinergics or opioid analgesics) contribute to the development of this condition.[2][8]

Pathophysiology

[edit]

The exact mechanism is not known. The probable explanation is imbalance in the regulation of colonic motor activity by the autonomic nervous system.[1] It has been postulated that reactivation of varicella zoster virus (which causes chickenpox and shingles) in the enteric ganglia may be a cause of Ogilvie syndrome.[11]

Acute megacolon develops because of abnormal intestinal motility. Normal colonic motility requires integration of myogenic, neural, and hormonal influences. The enteric nervous system is independent but is connected to the central nervous system by sympathetic and parasympathetic nerves. The targets of the enteric neurons are muscle cells, secretory cells, endocrine cells, microvasculature, and inflammatory cells. The neurons in the enteric plexuses are stimulated by a food bolus, which both distends the gut and stimulates the mucosal surface, leading to the release of factors that stimulate interneurons. The stimulated interneurons transmit excitatory signals proximally, which cause contraction and inhibitory signals distally, and these in turn cause relaxation. These signals are transmitted by the neurotransmitters acetylcholine and serotonin, among others.[12]

Acute megacolon can also lead to ischemic necrosis in massively dilated intestinal segments. This is explained by Pascal's law and Laplaces's law. Pascal's principle states that a change in pressure at any point in an enclosed fluid at rest is transmitted undiminished to all points in the fluid; the pressure across all parts of the lumen is equal. Laplace's law states that:

where T is wall tension, P is pressure, r is the radius, and t is wall thickness. Since the wall tension is proportionate to the radius, a dilated intestinal segment has a greater wall tension than a nondilated segment; if the dilatation and tension are sufficiently great, blood flow may be obstructed and ischemia of the bowel will occur.[12] Ogilivie syndrome may precipitate volvulus.[citation needed]

Diagnosis

[edit]

Diagnosis starts with physical exam, observation, and interview of the patient. Imaging to diagnose dilation of the colon involves one view abdominal xray or obstruction series (PA chest, erect abdomen, and supine abdomen images). If further imaging is needed CT may be ordered.[13]

Treatment

[edit]

It usually resolves with conservative therapy stopping oral ingestions and employing a nasogastric tube,[2] but resolution may require colonoscopic decompression which is successful in 70% of the cases. A study published in the New England Journal of Medicine showed that neostigmine is a potent pharmacological way of decompressing the colon.[1] According to the American Society for Gastrointestinal Endoscopy (ASGE), it should be considered prior to colonoscopic decompression. The use of neostigmine is not without risk since it can induce bradyarrhythmia and bronchospasms.[8] Therefore, atropine should be within immediate reach when this therapy is used.[1][2][3]

Prognosis

[edit]

Ogilvie syndrome is a serious medical disorder. Its mortality rate can be as high as 30%.[8] The high rate is likely a measure that this syndrome is seen in critically ill patients, rather than this syndrome being in itself lethal, although it can also present in otherwise healthy individuals (especially if the disorder was induced by pharmacologic agents). Drug-induced megacolon (such as from clozapine) has been associated with mortality as high as 27.5%.[12]

References

[edit]
  1. ^ a b c d Ponec RJ, Saunders MD, Kimmey MB (1999). "Neostigmine for the treatment of acute colonic pseudo-obstruction". N. Engl. J. Med. 341 (3): 137–41. doi:10.1056/NEJM199907153410301. PMID 10403850.
  2. ^ a b c d e Feldman, Mark; Friedman, Lawrence S.; Sleisenger, Marvin H. (July 2002). Sleisenger & Fordtran's Gastrointestinal and Liver Disease (7th ed.). Elsevier. ISBN 978-0-7216-8973-9.
  3. ^ a b Pratt DS, Epstein SK (2000). "Recent advances in critical care gastroenterology". Am. J. Respir. Crit. Care Med. 161 (5): 1417–20. doi:10.1164/ajrccm.161.5.16159. PMID 10806132.
  4. ^ Ogilvie H (1948). "Large-intestine Colic due to Sympathetic Deprivation". Br Med J. 2 (4579): 671–673. doi:10.1136/bmj.2.4579.671. PMC 2091708. PMID 18886657. Reproduced in: Ogilvie WH (December 1987). "William Heneage Ogilvie 1887-1971. Large-intestine colic due to sympathetic deprivation. A new clinical syndrome". Dis. Colon Rectum. 30 (12): 984–7. doi:10.1007/BF02554291. PMID 3319452. S2CID 68079923.
  5. ^ Sir William Heneage Ogilvie at Who Named It?
  6. ^ Haubrich WS (2008). "Ogilvie of the Ogilvie Syndrome". Gastroenterology. 135 (2): 337. doi:10.1053/j.gastro.2008.06.071.
  7. ^ Cleveland Clinic medical professional (2023-03-08). "What Is Ogilvie Syndrome (Acute Colonic Pseudo-Obstruction)?". Cleveland Clinic. Retrieved 2024-04-15.
  8. ^ a b c d Irwin, Richard S.; Rippe, James M. (January 2003). Intensive Care Medicine. Lippincott Williams & Wilkins, Philadelphia & London. ISBN 0-7817-3548-3. Archived from the original on 2005-11-07. {{cite book}}: |website= ignored (help)
  9. ^ Skeik N, Jabr FI (2009). "Ogilvie Syndrome". Consultant. 49 (2).
  10. ^ Tenofsky PL, Beamer L, Smith RS (2000). "Ogilvie syndrome as a postoperative complication". Arch Surg. 135 (6): 682–6, discussion 686–7. doi:10.1001/archsurg.135.6.682. PMID 10843364.
  11. ^ Gershon, A. A. (2013). "Varicella zoster vaccines and their implications for development of HSV vaccines". Virology. 435 (1): 29–36. doi:10.1016/j.virol.2012.10.006. PMC 3595154. PMID 23217613.
  12. ^ a b c Alam HB, Fricchione GL, Guimaraes AS, Zukerberg LR (October 2009). "Case records of the Massachusetts General Hospital. Case 31-2009. A 26-year-old man with abdominal distention and shock". N. Engl. J. Med. 361 (15): 1487–96. doi:10.1056/NEJMcpc0900643. PMID 19812406.
  13. ^ Conner S, Nassereddin A, Mitchell C (2 July 2021). Ogilvie Syndrome. Treasure Island (FL): StatPearls Publishing [Internet]. PMID 30252358.
[edit]
Retrieved from "https://wiki.riteme.site/w/index.php?title=Ogilvie_syndrome&oldid=1260921076"